Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Acquired Immune Deficiency Syndrome

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Acquired Immune Deficiency Syndrome in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benmehdi, H; Bensaid, O; Clayette, P; Dereuddre-Bosquet, N; Dive, G; Heymans, F; Lamouri, A; Martin, M; Redeuilh, C; Sallem, W; Serradji, N1
Clayette, P; Dereuddre-Bosquet, N; Dive, G; Heymans, F; Sallem, W; Serradji, N1
Choi, YB; Dzenko, KA; Gelbard, HA; Genis, P; Jett, M; Nottet, HS; Swindells, S; Wang, L; White, R; Zhang, D1
Bazan, NG; Block, AL; Braquet, P; Squinto, SP1
Sudan, BJ1

Other Studies

5 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Acquired Immune Deficiency Syndrome

ArticleYear
Structure-activity relationships in platelet-activating factor. Part 13: synthesis and biological evaluation of piperazine derivatives with dual anti-PAF and anti-HIV-1 or pure antiretroviral activity.
    Bioorganic & medicinal chemistry, 2006, Dec-01, Volume: 14, Issue:23

    Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Anti-Retroviral Agents; Dementia; Dose-Response Relationship, Drug; HIV-1; Humans; Piperazines; Platelet Activating Factor; Structure-Activity Relationship

2006
Structure-activity relationships in platelet-activating factor. Part 14: synthesis and biological evaluation of piperazine derivatives with dual anti-PAF and anti-HIV-1 activity.
    Bioorganic & medicinal chemistry, 2006, Dec-01, Volume: 14, Issue:23

    Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Dementia; Dose-Response Relationship, Drug; HIV-1; Humans; Piperazines; Platelet Activating Factor; Structure-Activity Relationship

2006
Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin.
    Journal of virology, 1994, Volume: 68, Issue:7

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Dementia Complex; Animals; Astrocytes; Cell Survival; Cells, Cultured; Child; Child, Preschool; Fetus; HIV-1; Humans; Infant; Middle Aged; Monocytes; Neurons; Platelet Activating Factor; Rats

1994
Platelet-activating factor activates HIV promoter in transfected SH-SY5Y neuroblastoma cells and MOLT-4 T lymphocytes.
    Journal of molecular neuroscience : MN, 1990, Volume: 2, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Animals; Drug Design; Gene Expression Regulation, Viral; Genes, Viral; HIV; Humans; Leukemia-Lymphoma, Adult T-Cell; Neuroblastoma; Platelet Activating Factor; Promoter Regions, Genetic; Recombinant Fusion Proteins; Repetitive Sequences, Nucleic Acid; Stimulation, Chemical; T-Lymphocytes; Transfection; Tumor Cells, Cultured

1990
Ketoconazole, leukotrienes, Paf-acether and nicotine as a hapten: the possible aetiology of seborrhoeic dermatitis.
    Medical hypotheses, 1987, Volume: 23, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Antipsychotic Agents; Dermatitis, Seborrheic; Haptens; Humans; Ketoconazole; Leukotriene B4; Malassezia; Models, Biological; Nicotine; Platelet Activating Factor

1987